By the time a biopsy confirms the diagnosis, the disease is in its chronicstage, often with severe scarring of the liver and the threat of cancer and death.
Novartis ' (nyse: NVS - news - people ) Gleevec, the first targeted cancer therapy, was approved after mid-stage trials in which it helped patients with chronic myelogenous leukemia.